Antisense Therapeutics Limited
ATHJF · OTC
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Market Cap | $15,874 | $50,187 | $64,056 | $101,203 |
| - Cash | $11,867 | $10,967 | $19,233 | $6,020 |
| + Debt | $40 | $142 | $227 | $307 |
| Enterprise Value | $4,047 | $39,362 | $45,050 | $95,489 |
| Revenue | $2,968 | $1,580 | $1,778 | $578 |
| % Growth | 87.9% | -11.1% | 207.7% | – |
| Gross Profit | $2,906 | $1,485 | $1,689 | $474 |
| % Margin | 97.9% | 94% | 95% | 82.1% |
| EBITDA | -$11,900 | -$11,368 | -$5,827 | -$8,100 |
| % Margin | -400.9% | -719.5% | -327.7% | -1,402% |
| Net Income | -$11,919 | -$11,380 | -$5,812 | -$8,061 |
| % Margin | -401.6% | -720.3% | -326.9% | -1,395.1% |
| EPS Diluted | -0.014 | -0.017 | -0.009 | -0.015 |
| % Growth | 20.6% | -84.8% | 38.3% | – |
| Operating Cash Flow | -$10,116 | -$8,151 | -$7,805 | -$5,834 |
| Capital Expenditures | -$4 | -$29 | -$4 | -$8 |
| Free Cash Flow | -$10,119 | -$8,181 | -$7,809 | -$5,843 |